Literature DB >> 19221418

Constant illumination induces Alzheimer-like damages with endoplasmic reticulum involvement and the protection of melatonin.

Zhi-Qun Ling1, Qing Tian, Li Wang, Zheng-Qi Fu, Xiao-Chuan Wang, Qun Wang, Jian-Zhi Wang.   

Abstract

Most patients with Alzheimer's disease (AD) present decreased levels of melatonin, a day-night rhythm-related hormone. To investigate the role of melatonin deficiency in AD, we used constant illumination to interrupt melatonin metabolism and measured some of the AD-like alterations in rats. Concomitant with decreased serum melatonin, the rats developed spatial memory deficits, tau hyperphosphorylation at multiple sites, activation of glycogen synthase kinase-3 and protein kinase A, as well as suppression of protein phosphatase-1. Prominent oxidative damage and organelle lesions, demonstrated by increased expression of endoplasmic reticulum (ER) stress-related proteins including BiP/GRP78 and CHOP/GADD153, decreased number of rough ER and free ribosome, thinner synapses, and increased superoxide dismutase and monoamine oxidase were also observed in the light exposed rats. Simultaneous supplement of melatonin partially arrested the behavioral and molecular impairments. It is suggested that melatonin deficiency may be an upstream effector responsible for the AD-like behavioral and molecular pathologies with ER stress-involved mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19221418     DOI: 10.3233/JAD-2009-0949

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  18 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

Review 2.  Reactive oxygen species in the regulation of synaptic plasticity and memory.

Authors:  Cynthia A Massaad; Eric Klann
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

3.  Melatonin Rescue Oxidative Stress-Mediated Neuroinflammation/ Neurodegeneration and Memory Impairment in Scopolamine-Induced Amnesia Mice Model.

Authors:  Tahir Muhammad; Tahir Ali; Muhammad Ikram; Amjad Khan; Sayed Ibrar Alam; Myeong Ok Kim
Journal:  J Neuroimmune Pharmacol       Date:  2018-11-27       Impact factor: 4.147

Review 4.  Modulation of serine/threonine phosphatases by melatonin: therapeutic approaches in neurodegenerative diseases.

Authors:  Raquel L Arribas; Alejandro Romero; Javier Egea; Cristóbal de Los Ríos
Journal:  Br J Pharmacol       Date:  2018-06-19       Impact factor: 8.739

Review 5.  Pharmacological Effects of Melatonin as Neuroprotectant in Rodent Model: A Review on the Current Biological Evidence.

Authors:  Hui Ying Tan; Khuen Yen Ng; Rhun Yian Koh; Soi Moi Chye
Journal:  Cell Mol Neurobiol       Date:  2019-08-21       Impact factor: 5.046

Review 6.  Snapshot: implications for melatonin in endoplasmic reticulum homeostasis.

Authors:  Wei Hu; Zhiqiang Ma; Shouyin Di; Shuai Jiang; Yue Li; Chongxi Fan; Yang Yang; Dongjin Wang
Journal:  Br J Pharmacol       Date:  2016-11-16       Impact factor: 8.739

7.  Melatonin Protects SH-SY5Y Neuronal Cells Against Methamphetamine-Induced Endoplasmic Reticulum Stress and Apoptotic Cell Death.

Authors:  Pawaris Wongprayoon; Piyarat Govitrapong
Journal:  Neurotox Res       Date:  2016-07-01       Impact factor: 3.911

8.  Therapeutic applications of melatonin.

Authors:  Ifigenia Kostoglou-Athanassiou
Journal:  Ther Adv Endocrinol Metab       Date:  2013-02       Impact factor: 3.565

Review 9.  Melatonin in Alzheimer's disease.

Authors:  Li Lin; Qiong-Xia Huang; Shu-Sheng Yang; Jiang Chu; Jian-Zhi Wang; Qing Tian
Journal:  Int J Mol Sci       Date:  2013-07-12       Impact factor: 5.923

10.  C/EBP homologous protein (CHOP) mediates neuronal apoptosis in rats with spinal cord injury.

Authors:  Zhangfu Wang; Chuanyi Zhang; Zhenghua Hong; Haixiao Chen; Weifu Chen; Guofu Chen
Journal:  Exp Ther Med       Date:  2012-10-12       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.